Pharmaceuticals by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Takeda Pharmaceutical leads the 33 pharmaceuticals ranked by P/E ratio, at 309, ahead of Merck & Co (145) and Ligand Pharmaceuticals (118). Figures as of 18 Nov 2026, 13:57 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
33
First
Takeda Pharmaceutical309
Median
40.7
Combined market value
$5.16T
Countries
10
Not ranked
28no P/E ratio on file

Market values as of .

Pharmaceuticals by P/E ratio
#CompanyP/E ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Takeda PharmaceuticalTAK · Health Care309$69.1B$21.64 0.23% up 54% up Japan
2Merck & CoMRK · Health Care145$353.4B$143.37 0.75% down 51% up United States
3Ligand PharmaceuticalsLGND · Health Care118$5.9B$293.81 2.62% down 43% up United States
4Teva Pharmaceutical IndustriesTEVA · Health Care99.1$49.7B$42.62 0.12% up 74% up Israel
5TG TherapeuticsTGTX · Health Care93.6$9.5B$62.71 0.08% down 107% up United States
6Kiniksa Pharmaceuticals InternationalKNSA · Health Care72.1$7.5B$95.11 0.93% up 126% up United Kingdom
7Jazz PharmaceuticalsJAZZ · Health Care71.2$15.5B$240.71 0.39% up 37% up Ireland
8BeOne MedicinesONC · Health Care53.0$47.2B$413.26 0.48% up 17% up Switzerland
9Amneal PharmaceuticalsAMRX · Health Care52.8$7.4B$21.12 0.52% down 83% up United States
10Corcept TherapeuticsCORT · Health Care52.7$7.7B$70.07 1.23% up 8% down United States
11AbbVieABBV · Health Care50.3$517.6B$292.82 0.59% down 26% up United States
12Eli LillyLLY · Health Care45.9$1.26T$1,415.55 1.13% down 35% up United States
13Royalty PharmaRPRX · Health Care44.9$39.5B$68.68 0.23% up 78% up United States
14GenmabGMAB · Health Care44.4$32B$51.96 0.76% up 70% up Denmark
15Johnson & JohnsonJNJ · Health Care42.3$670.9B$278.70 1.36% down 38% up United States
16Dr. Reddy's LaboratoriesRDY · Health Care41.1$12.3B$14.79 0.61% up 5% up India
17PfizerPFE · Health Care40.7$162.3B$28.47 1.35% down 14% up United States
18Abbott LaboratoriesABT · Health Care39.1$181.4B$104.71 2.55% down 17% down United States
19Vertex PharmaceuticalsVRTX · Health Care34.4$135.4B$534.20 0.67% down 27% up United States
20NovartisNVS · Health Care30.4$300.5B$159.13 0.67% down 25% up Switzerland
21Protagonist TherapeuticsPTGX · Health Care26.4$8.1B$124.67 0.13% down 46% up United States
22AstraZenecaAZN · Health Care25.8$282.7B$182.27 0.95% down 2% up United Kingdom
23SanofiSNY · Health Care23.6$114.1B$47.53 1.78% down 4% down France
24United TherapeuticsUTHR · Health Care22.0$24.9B$584.10 0.64% down 23% up United States
25Regeneron PharmaceuticalsREGN · Health Care21.2$99.1B$957.76 0.56% up 36% up United States
26Ascendis PharmaASND · Health Care17.8$17.8B$271.19 0.20% down 28% up Denmark
27GSKGSK · Health Care17.2$98.7B$49.24 2.32% down 6% up United Kingdom
28ZoetisZTS · Health Care14.2$33.9B$83.48 1.08% down 29% down United States
29Bristol-Myers SquibbBMY · Health Care13.6$125.4B$61.35 2.51% down 34% up United States
30GrifolsGRFS · Health Care10.4$5.9B$8.63 1.15% down 1% up Spain
31Novo NordiskNVO · Health Care10.3$179.4B$40.70 2.16% down 17% down Denmark
32Alnylam PharmaceuticalsALNY · Health Care7.9$21B$156.50 2.02% down 66% down United States
33Edgewise TherapeuticsEWTX · Health Care5.0$4.6B$42.04 3.75% down 88% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. 28 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which pharmaceuticals rank first by P/E ratio?

Takeda Pharmaceutical (309), Merck & Co (145) and Ligand Pharmaceuticals (118) are the top three of the 33 pharmaceuticals ranked by P/E ratio as of 18 Nov 2026, 13:57 UTC.

How many pharmaceuticals are in this ranking?

33 are ranked by P/E ratio. 28 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

The 33 pharmaceuticals ranked by P/E ratio have a combined market value of $5.16T as of 18 Nov 2026, 13:57 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Pharmaceuticals by P/E ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.